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Endocannabinoids are pleiotropic lipid messengers that play pro-homeostatic role in
cellular physiology by strongly influencing intracellular Ca2+ concentration through the
activation of cannabinoid receptors. One of the best-known endocannabinoid ‘2-AG’
is chemically unstable in aqueous solutions, thus its molecular rearrangement, resulting
in the formation of 1-AG, may influence 2-AG-mediated signaling depending on the
relative concentration and potency of the two isomers. To predict whether this molecular
rearrangement may be relevant in physiological processes and in experiments with 2-
AG, here we studied if isomerization of 2-AG has an impact on 2-AG-induced, CB1-
mediated Ca2+ signaling in vitro. We found that the isomerization-dependent drop in
effective 2-AG concentration caused only a weak diminution of Ca2+ signaling in CB1
transfected COS7 cells. We also found that 1-AG induces Ca2+ transients through the
activation of CB1, but its working concentration is threefold higher than that of 2-AG.
Decreasing the concentration of 2-AG in parallel to the prevention of 1-AG formation
by rapid preparation of 2-AG solutions, caused a significant diminution of Ca2+ signals.
However, various mixtures of the two isomers in a fix total concentration – mimicking the
process of isomerization over time – attenuated the drop in 2-AG potency, resulting in
a minor decrease in CB1 mediated Ca2+ transients. Our results indicate that release of
2-AG into aqueous medium is accompanied by its isomerization, resulting in a drop of
2-AG concentration and simultaneous formation of the similarly bioactive isomer 1-AG.
Thus, the relative concentration of the two isomers with different potency and efficacy
may influence CB1 activation and the consequent biological responses. In addition, our
results suggest that 1-AG may play role in stabilizing the strength of cannabinoid signal
in case of prolonged 2-AG dependent cannabinoid mechanisms.
Keywords: 2-AG, 1-AG, cannabinoid, CB1, modulation, calcium signaling
Chemical compounds studied in this article: 2-arachidonoyglycerol (2-AG, PubChem CID: 5282280); 1-arachidonoyl-sn-
glycerol (1-AG, PubChem CID: 16019980); AM251 (PubChem CID: 2125); adenosine triphosphate (ATP, PubChem CID:
5957)
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INTRODUCTION
Recognized as ubiquitous regulators of several physiological and
pathological processes, endogenous cannabinoids control various
fundamental biological phenomena from cell proliferation and
metabolism to immune response and neurotransmission
(Katona and Freund, 2012; Galve-Roperh et al., 2013; Hebert-
Chatelain et al., 2014; Cabral et al., 2015; Maccarrone et al.,
2015; Mazier et al., 2015). Importantly, cannabinoids exert their
functions in the nervous system by modulating both excitatory
and inhibitors neurotransmission, influencing a plethora of
neurobiological phenomena from pain processing and motor
coordination to anxiety and memory consolidation (D’Amico
et al., 2004; Cannizzaro et al., 2006; Kano et al., 2009; Katona
and Freund, 2012). The endocannabinoid system is usually
described as a surprisingly diverse molecular toolbox, consisting
of cannabinoid receptor type 1 and 2 (CB1 and CB2), their
lipid-derived endogenous ligands known as endocannabinoids,
and enzymes responsible for biosynthesis and degradation of
endocannabinoids. Moreover, release of endocannabinoids
not only activates CB1 and CB2 cannabinoid receptors (Andó
et al., 2012), but also leads to the formation of various bioactive
oxidative metabolites which broaden the spectrum of biological
actions associated with endocannabinoid mobilization (Rouzer
and Marnett, 2011). The best-characterized endocannabinoids,
anandamide and 2-arachidonoyl-sn-glycerol (2-AG) share
several common features. Both ligands are synthesized on
demand from lipid precursors found in cell membranes, typically
upon G-protein coupled receptor activation or depolarization,
and released into the extracellular space (Kano et al., 2009).
Anandamide and 2-AG target both CB1 and CB2 receptors
(Pertwee, 2006) and influence cytosolic Ca2+ concentration (De
Petrocellis and Di Marzo, 2009), and their effects are terminated
primarily by enzymatic degradation including hydrolytic and
also oxidative routes (Muccioli, 2010). However, the mechanisms
decreasing the concentration of released 2-AG and anandamide
are characteristically distinct. Although anandamide is stable
chemically in organic solvents and aqueous solutions, 2-AG is
prone to molecular rearrangement in water based media, i.e., the
arachidonyl moiety moves from the 2-position to the 1-position
of glycerol. This non-enzymatic isomerization, known as acyl
migration, results in the formation of 1-arachidonoyl-sn-glycerol
(1-AG), which is thermodynamically more stable than 2-AG, and
the reaction proceeds until it reaches an equilibrium at 1:9 ratio of
2-AG and 1-AG (Martin, 1953). Still, in most biological systems,
2-AG mediated signaling is currently thought to be terminated
by one or more degradative enzymes, such as monoacylglycerol
lipase (MGL), fatty acid amide hydrolase (FAAH), α/β hydrolase
domain 6 and 12 (ABHD6, ABHD12), cyclooxygenase-2 and
also lipoxygenases (Muccioli, 2010; Savinainen et al., 2012).
Depending on tissue and cell type, participation of these enzymes
in the elimination of 1-AG and 2-AG is highly variable. In
the central nervous system, for instance, MGL is responsible
for approximately 85% of 2-AG catabolism (Dinh et al., 2002,
2004; Blankman et al., 2007), whereas in macrophages, ABHD12
may play a more prominent role as a 2-AG degrading enzyme
(Fiskerstrand et al., 2010; Savinainen et al., 2012). Moreover,
elimination of 1-AG and 2-AG is further diversified by the
substrate preference of hydrolases. MGL has been demonstrated
to equally accept and degrade both 1-AG and 2-AG, whereas
ABHD6 and ABHD12 show preference to 1-AG over 2-AG
(Navia-Paldanius et al., 2012). Thus, when 2-AG is released into
aqueous extracellular space, the elimination rate is presumably
influenced mostly by enzymatic processes and partly by acyl
migration. Interestingly, however, 2-AG degrading enzymes are
not necessarily found in the proximity of cannabinoid receptors,
which is well illustrated in the superficial spinal dorsal horn,
where most CB1 receptor-carrying axon terminals and glial
processes lack MGL (Hegyi et al., 2009; Horváth et al., 2014;
Dócs et al., 2015). Such molecular arrangement may provide
opportunity for acyl migration to exceed enzymatic degradation,
yielding biologically significant increasing concentration of
1-AG over time. Since it influences a plethora of physiological
processes, 2-AG mediated intercellular signaling has extensively
been investigated, including quantitative analysis of tissue levels
of 2-AG, which is highly dependent on cell and tissue type,
sample preparation and experimental settings. Interpretation
also influence 2-AG quantities found in different papers, since
2-AG amounts are frequently expressed as the summed values for
both 1- and 2-isomers, because isomerization was also identified
as a post-isolation artifact (Ferrer et al., 2003; Van Sickle et al.,
2005; Suplita et al., 2006). This may explain, that in the brain,
for instance, reported tissue level of 2-AG varies from 0.23 to 65
nmol/g tissue (Sugiura et al., 2006).
To complicate matters further, several investigators found that
1-AG is a biologically active compound acting on CB1 receptor
and increasing intracellular Ca2+ concentration (Sugiura et al.,
1999), and it also activates TRPV1 (Zygmunt et al., 2013). Activity
of 2-AG in cerebellar membrane preparations was also proposed
to consist of activity of both 1- and 2-isomers (Savinainen
et al., 2001). Thus, these findings suggest that isomerization
yields in another biologically active compound which targets
the same receptors as its precursor. This mechanism is not
unusual in the endocannabinoid system, since oxidative and
hydrolytic end-products of endocannabinoid catabolism are also
bioactive (Rouzer and Marnett, 2011). Thus, acyl migration
and consequent 1-AG formation might have an impact on
endocannabinoid signaling, since the two isomers will most
likely compete for ligand binding sites of CB1 receptors, which
would represent an unusual mechanism, where the strength of
net cannabinoid signal depends on the relative concentration
and potency of the two isomers. Importantly, isomerization
may or may not influence cannabinoid-dependent mechanisms
depending on the half-life of acyl migration and the time-
frame of the biological phenomenon. Prolonged CB1-mediated
processes, such as an endocannabinoid tone can most probably
be influenced by isomerization even if it has longer half-
life. However, to influence rapid cannabinoid actions, like
depolarization-induced suppression of excitatory or inhibitory
synaptic transmission (DSE, DSI), acyl migration should proceed
with a half-life that has never described earlier.
Here we demonstrate that rearrangement of 2-AG into its
isomer 1-AG in water-based media is a moderately fast process,
but it indeed yields another biologically active compound that
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exerts its effect also through the activation of CB1 receptors. We
also show that, depending on the ratio of the two isomers, 1-
AG may either act as a weak competitive antagonist of 2-AG, or
its effect can also be additive to that of 2-AG maintaining CB1
receptor activation.
MATERIALS AND METHODS
Decomposition of 2-AG in Aqueous
Solutions
The endocannabinoid 2-AG and 1-AG were prepared and
extracted as described earlier (Higuchi et al., 2010; Zhang
et al., 2010; Zoerner et al., 2012) with some modifications.
Briefly, 250 µl HBSS containing 0.625 µg/mL anandamide was
spiked with either 2-AG (Cayman Chemical) or 1-AG (Cayman
Chemical) dissolved in acetonitrile in a final concentration of
0.25 µg/mL) in test tubes, and incubated at 37◦C for 1.25, 2.5,
5, or 10 min. Thereafter, the samples were frozen in liquid
nitrogen and kept there until further processing. Zero time
samples were spiked with 2-AG after freezing in liquid nitrogen.
During sample preparation, 10 µl trifluoroacetic acid and 1000 µl
hexane was added to the frozen samples, which were allowed
to melt during constant vigorous shaking at 1400 rpm. This
allowed the endocannabinoids to be transferred to the organic
phase immediately after melting. TFA was added to stop the
base-catalyzed isomerization. Then, the phases were separated
by centrifugation at 13000 rpm for a minute. An 800 µl aliquot
of the hexane layer was evaporated to dryness, redissolved in
40 µl acetonitrile containing 0.1% formic acid. Then, 20 µl of
this solution was injected into the LC/MS. The experiment was
performed in three replicates for each time point.
Quantification of 1-AG and 2-AG with
LC-MS
Changes in the amounts and ratio of 2-AG and 1-AG were
determined on a YMC-Triart C18 (100 mm × 3.0 mm, 1.9 µm,
12 nm, YMC Co., Ltd, Kyoto 600-8106, Japan) column, using
an Accela HPLC system (Thermo Electron Corp., San Jose, CA,
USA) eluted with a gradient of acetonitrile (A) and water (B)
containing 0.1%(V/V) formic acid each. The gradient was from
60% of A (hold for 2 min) to 90% A over 7 min, hold for 6 min
and return to initial conditions and hold for 5 min to equilibrate
the column. The LC system was coupled with a Thermo LTQ XL
mass spectrometer (Thermo Electron Corp., San Jose, CA, USA)
using positive-ion ESI mode as a method of ionization. The ion
injection time was set to 100 ms. ESI parameters were as follows:
spray voltage: 5 kV, source heater temperature: 280◦C, capillary
temperature of: 300◦C, sheath gas flow: 25 units N2, auxiliary gas
flow: 8 units N2. The tray temperature was set to 12◦C and the
column oven was set to 30◦C to perform the optimal retention of
the compounds in the reaction mixtures.
MS2 product-ion scans were obtained after collision-
induced dissociation with helium as the target gas. Compound
identification was based on their retention times (tR), HESI mass
spectra and MS2 with authentic compounds as references. 1-AG
and 2-AG levels were determined by LC-ESI-MS/MS in SRM
mode and calibration with solutions of known concentrations
of the analytes extracted for analyses. As an internal standard,
anandamide was added before each sample extraction. SRM
transitions were 379–287 for 1AG and 2AG and 348–287 for
ANA, respectively. For all analytes of interest, recovery was
calculated to be above 85% which is comparable to that published
by Zoerner et al. (2012).
Plasmid Construction
The mammalian expression vector pcDNA3 CB1 was used to
overexpress CB1 receptor in COS7 cell line [generous gift from
Mary Abood, Addgene plasmid # 13391, (Abood et al., 1997)].
To verify the successful transfection, the red fluorescent protein
(RFP) coding expression vector CMV-Brainbow-1.0 H (a gift
from Joshua Sanes, Addgene plasmid # 18720) was co-expressed
in the cells under the control of the same CMV promoter as the
pcDNA3-CB1 plasmid (Livet et al., 2007).
Cell Culture and Transfection
COS7 cells (originated from ATCC, kindly provided by the
Department of Biophysics, University of Debrecen) were grown
to ∼90% confluence (104 cell/cm2) in DMEM (Gibco, USA)
supplemented with 10% fetal bovine serum (Sigma-Aldrich,
USA), 100 U/ml penicillin, 100 mg/ml streptomycin and 2 mM
glutamine (Gibco, USA) under 5% CO2 at 37◦C. Prior to
electroporation, cells were detached from 75 cm2 culturing
flasks by incubation with Trypsin-EDTA (Sigma-Aldrich, USA),
pelleted by centrifugation (900 × g for 10 min) and resuspended
in DMEM (1.9 × 105 cell/ml). This suspension was used for
CB1/RFP co-transfection (20 µg/ml CB1 plasmid and 4 µg/ml
RFP plasmid) and for control RFP transfection (4 µg/ml
RFP plasmid). Electroporation was carried out by ECM830
electroporator (BTX, Harvard Apparatus, USA) using disposable
2 mm Gap Cuvette (Model No. 620, BTX, Harvard Apparatus,
USA). The electroporation protocol was as follows: 220 V, two
500 µs width pulses with 1 s intervals.
Ca2+ Measurements
Before Ca imaging experiments, transfected COS7cells were
loaded with 1 µM Fluo-8-AM in the presence of 0.01% pluronic
at room temperature for 30 min. Ca2+ imaging was carried
out with an Andor Zyla 5.5 sCMOS camera attached to a
differential spinning disk (DSD2, Andor Technology) built on
an Olympus IX-81 inverse microscope. Using a 10× objective
(NA:0.25), images of 540 pixels × 306 pixels (corresponding to
1400 mm × 790 mm field of view, which contained around
200 to 250 cells) were acquired at 15 frames per second with
Andor iQ3 software. Fluo-8 filled cells were excited at 488 nm
and emission was collected at 520 nm. Acquisition parameters
(illumination intensity, exposure time, readout time, frame rate)
were identical for all experiments. Changes in fluorescence
intensities were measured over the entire COS7 cell surface
by drawing freehand ROIs around single transfected COS7
cells with sharp RFP signal, that identified unequivocally the
entire contour of the transfected cell. Ca2+ variations were
estimated as changes of the fluorescence signal over baseline
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(1F/F0, where F0 was the average initial fluorescence). A region
of interest was considered to respond to the application of
a compound if 1F/F0 three times the standard deviation of
the baseline for at least five consecutive images. Experimental
data were analyzed with Microsoft Excel 2013 (Microsoft),
and FFT filtering to reduce noise and calculation of area
under the curve (AUC) were performed with Origin Pro
8.0 (Originlab, Northampton, MA, USA). Statistical analysis
was performed with two-tailed non-parametric Mann–Whitney
U test. The differences were considered significant when the p
level was< 0.05.
SDS PAGE and Western Blot
The COS7 samples were sonicated in 20 mM TRIS (pH 7.4)
lysis buffer supplemented with protease inhibitors (4 mM
EDTA, 2.5 mM EGTA, 2 mM PMSF, 26 µM benzamidine,
8 µM pepstatin A, 2 µg/ml soybean trypsin inhibitor, 2 µg/ml
leupeptin, 2 µg/ml aprotinin). The cell debris was removed by
centrifugation (10 min at 1500 g and 4◦C), then the supernatant
was again centrifuged (20 min at 12,000 g and 4◦C). The pellet
was resuspended in lysis buffer containing 1% TRITON X-100
and 0.1% SDS. The samples were stored at−70◦C until use.
The protein concentration of the samples was determined
using the detergent compatible BCA assay (Pierce, Rockford, IL,
USA). The samples were dissolved in reducing sample buffer
(50 µg protein/lane) and run on 10% SDS-polyacrylamide gels
(Laemmli, 1970). The separated proteins were electrophoretically
transferred onto PVDF membrane (Millipore, Bedford, MA,
USA).
The membranes were blocked with 10% bovine serum
albumin (Sigma) in TTBS solution (20 mM TRIS, 500 mM NaCl,
pH 7.5, 0.05% Tween-20). Membranes were incubated with anti-
CB1antibody (1:1000, Cayman Chemicals, Ann Arbor, MI, USA,
Cat. No: 10006590) for 2 h at room temperature. After extensive
washing with TTBS the membranes were incubated with
anti-rabbit IgG-HRP secondary antibody (DakoCytomation,
Glostrup, Denmark). The labeled protein bands were visualized
with 3, 3′-diaminobenzidine (Sigma).
Immunocytochemistry
Transfected COS7 cells were grown on 24-well glass bottom
plate and fixed with 4% paraformaldehyde dissolved in 0.1 M
phosphate buffer for 10 min. Cells were then treated with 10%
normal goat serum for 30 min, followed by an incubation with
anti-CB1 antibody (1:2000, Cayman Chemicals, Ann Arbor, MI,
USA, Cat. No: 10006590) for 2 h. After washing, goat anti-
rabbit IgG secondary antibody conjugated with Alexa Fluor 488
(1:1000, Invitrogen) was applied for 1 h, then cells were covered
with Vectashield-DAPI. Antibodies were diluted in PBS (pH 7.4)
containing 1% normal goat serum. All incubation steps were
carried out at room temperature.
Imaging of immunostained COS7 cells was carried out with
an Olympus IX-81 inverse microscope attached to a DSD2 an
Andor Zyla 5.5 sCMOS camera. Images were acquired using a
60× PlanApo N oil-immersion objective (NA: 1.40) and selecting
the “high signal” disk of DSD2, and processed with Adobe
Photoshop CS6.
The specificity of anti-CB1 antibody has extensively been
characterized earlier in our laboratory (Hegyi et al., 2009). To
test the specificity of the immunostaining protocol, transfected
COS7 were incubated according to the immunostaining protocol
described above with primary antibodies omitted or replaced
with 1% normal goat serum. No immunostaining was observed
under these conditions.
RESULTS
2-AG Rearranges Rapidly to 1-AG in
HBSS
Many studies reported rearrangement of 2-AG into 1-AG
(Figure 1A) under ambient conditions. In order to simulate the
conditions of our in vitro experiments to the highest possible
extent, Hank’s Balanced Salt Solution (HBSS), a commonly
used cell medium (HBSS) was spiked with 2-AG and the
decomposition curve at 37◦C was determined using LC-MS. The
other well-known endocannabinoid anandamide, which remains
stable during the analytical procedure (Zoerner et al., 2012), was
successfully used as internal standard to manage inaccuracies of
liquid–liquid extraction and injections. The peak of anandamide
showed no decrease over time.
In accordance with other publications employing RPMI
medium (Rouzer et al., 2002), we found that 2-AG is rapidly
converted to 1-AG also in HBSS (Figure 1B). The half-life of
conversion was 16.16 ± 3.74 min (without serum, extrapolated)
and 8.81 ± 2.51 min (with serum), which is within the same
order of magnitude as reported for other physiological solutions.
Differences may come from the differences in the media, and
from the different initial concentration of 2-AG, since Rouzer
et al. (2002) used 2 µg/mL (equal to 5 µM), while in our
experimental settings the concentration was close to the order
of magnitude used for the treatment of the cells (0.6 mM).
The latter is comparable to the concentration of the OH−
present, possibly leading to altered kinetics of the reaction. The
ratio of the two peaks is significantly changed within 2 min
(Figures 1C–E). We have to add, however, that our experiments
were carried out in pure physiological solution, free of cells or
biological membranes, which helped us to significantly reduce
the time frame of sample preparation and concomitant artifactual
isomerization. This approach is different from those publications,
in which 1-AG and 2-AG were isolated from biological samples
requiring lengthy purification steps that provides possibility
for post-isolation artifacts (Ferrer et al., 2003; Suplita et al.,
2006).
Importantly, acyl migration takes place in any protic
solvent (including water) and is actually catalyzed by OH−
present in all aqueous solutions at physiological pH (Rouzer
et al., 2002). Therefore, we assume that 2-AG isomerizes to
1-AG on the minute timescale in any water-based media
including the one used in the present study. In addition,
rearrangement of 2-AG is accelerated in the presence of
protein, that is likely to act as a catalytic surface that
increases the reaction speed. Since actually all intracellular or
extracellular fluids of the living organisms contain proteins,
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FIGURE 1 | Isomerization of 2-AG in HBSS. (A) Structure and isomerization of 2-AG and 1-AG. (B) Changes in the amounts of 2-AG (magenta) and 1-AG (blue)
over time in HBSS with (circles) or without (squares) serum. (C–D) Representative chromatograms illustrating the separation of 2-AG (magenta arrowhead) and 1-AG
(blue arrowhead) in HBSS containing serum in the 0th min (C) and 10th min (D) of isomerization. (E) Change in the ratio of 2-AG and 1-AG due to acyl migration
over time in HBSS with (circles) or without (squares) serum.
acyl migration is likely to be of significance in vivo as
well.
Overexpression of CB1 Receptor in
COS7 Cells
First, we aimed to establish a simple in vitro model expressing
CB1 to study the cellular effects of 2-AG and 1-AG. Thus,
we transiently transfected COS7 cells with pcDNA3 CB1 by
electroporation after 5–7 passages to achieve overexpression
of CB1 receptor, and verified the expression of CB1 by
immunocytochemistry. CB1 immunostained puncta could be
observed in high densities along the cell membrane and also in
the cytoplasm of the transfected cells, identified by their RFP
expression (Figure 2A). We also quantified CB1 protein levels
3 days after transfection. Western blot analysis with an anti-
CB1 antibody confirmed the expression of CB1 in COS7 cells
(Figure 2B), and found an approximately 5.6-fold increase in
CB1 expression in the transfected cells (Figure 2C).
Despite Its Conversion into 1-AG, the
Biological Effects of 2-AG at
Cannabinoid Receptors Are Barely
Affected on the Minute Timescale
Since 2-AG gradually disappears in HBSS due to isomerization,
acyl migration may strongly influence the potency of 2-AG.
Thus, we examined the effects of decreasing effective 2-AG
concentration on CB1-induced Ca2+ transients by loading CB1
transfected COS7 cells with the fluorescent Ca2+ indicator Fluo-
8-AM and monitoring Ca2+ signals evoked by administration of
2-AG. We identified all CB1-transfected cells in the visual field
based on the RFP signal, and selected cells with sharp and distinct
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FIGURE 2 | Verification of CB1 receptor expression in transiently transfected COS7 cells. (A) Immunofluorescent staining against CB1 receptor
demonstrates strong expression of CB1 in transfected COS7 cells co-expressing RFP for easy identification. (B) Western blot analysis of CB1 receptor expression in
transfected (TF) and also in native (control) COS7 cells. (C) Densitometry showed a fivefold increase in CB1 expression in transfected COS7 cells.
RFP-defined contour for analysis. To allow reliable comparison
of the experimental data, we performed all Ca2+ imaging with
identical settings and acquisition parameters. Changes in the
fluorescence signal intensity over baseline (1F/F0) were plotted
against time to illustrate alterations in the intracellular Ca2+
concentration. In the end of all Ca2+ measurement experiments,
we applied 180 µM ATP as final treatment to verify viability
of cells and obtain maximum Ca2+ response. Cells showing
no response to ATP treatment were discarded from further
analysis. Values of the AUC of Ca2+ transients evoked by
ATP were considered as maximal responses for each cell. AUC
values of cannabinoid-evoked Ca2+ signals were also calculated
and normalized against responses to ATP by expressing CB1-
dependent responses as percentage of maximal response. Cells
in each well were treated only once to avoid desensitization of
CB1 and allow registration of consistent responses. With these
experimental settings, we treated the cells with 2-AG solution,
that had a 1 µM starting concentration and was administered
either immediately (“0-min experiment”), or incubated for 2.5, 5,
and 10 min at room temperature before application. This amount
of 2-AG is about 50% of the concentration that evokes maximal
response, so any change in 2-AG levels will be approximately
linearly reflected by changes is the Ca2+ transients. As shown
in Figure 3, freshly prepared and immediately applied 2-AG
induced robust transient-like elevation of intracellular Ca2+
concentration in CB1 transfected COS7 cells (Figure 3A;
Table 1). Two and half minutes after preparation, 2-AG evoked
Ca2+ signals with AUC values practically identical to that of
0-min experiment (Figure 3B; Table 1), and an additional
incubation of 2-AG solution for 2.5 min caused only a marked
diminution of Ca2+ responses (Figure 3C; Table 1). Application
of 2-AG 10 min after preparation caused a weak and still not
significant attenuation in cytosolic Ca2+ elevation (Figure 3D;
Table 1). As we have shown, 2-AG is readily converted into 1-
AG with a half-life of 8.8 min. However, the decrease in 2-AG
concentration was not reflected in the evoked Ca2+ signals, as
we detected only an insignificant minor decrease in biological
responses.
1-AG Concentration-Dependently
Increases Intracellular Ca2+
Concentration by Activating Cannabinoid
Receptors
As the arachidonoyl moiety moves from the 2-position to the
1-position of glycerol, not only the effective concentration of
2-AG decreases continuously, but also the amount of 1-AG
increases gradually in aqueous solutions until the equilibrium
between 2-AG and 1-AG is reached at approximately 1:9 ratio.
Here we investigated if the 1-isomer interacts with CB1 in
our experimental conditions, and compared its pharmacological
properties to those of 2-AG. We administered 1-AG solution
of various concentration spanning from 10 nM to 100 µM
to CB1 transfected COS7 cells, and examined if the treatment
induced any change in the intracellular Ca2+ concentration in
our experimental conditions. As shown in Figures 4A–E,N and
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FIGURE 3 | Time-dependent change in the potency of 2-AG. (A–E)
Average Ca2+ transients in CB1 transfected COS7 cells induced by 1 mM
2-AG (magenta arrowhead), administered immediately (A), 2.5 min (B), 5 min
(C) or 10 min (D) after dissolving the ligand in HBSS. (E) As isomerization
proceeds, decreasing concentrations of 2-AG (see also Figure 1B) induce
Ca2+ transients with only slightly diminished AUC values. Each data point
represents an average of AUC values of Ca2+ transients evoked by 1 mM
2-AG, expressed as percentage of response to 180 mM ATP (black
arrowhead).
Table 2, starting at low micromolar concentration, 1-AG evoked
Ca2+ transients with strictly concentration-dependent amplitude
and AUC values.
To compare the potency and efficacy of the two isomers,
we repeated the above experiment, now by applying various
concentration of 2-AG spanning from 10 nM to 100 µM. In
TABLE 1 | Time-dependent decrease in area under the curve (AUC) values
of Ca2+ transients (expressed as percentage of response to 180 mM ATP)
in response to 2-AG that was left in HBSS containing 10% serum to allow
isomerization.
Time (min) AUC (% of ATP response) n
0 58.92 ± 2.326 150
2.5 55.3 ± 1.025 141
5 52.96 ± 1.777 139
10 50.22 ± 2.434 137
agreement with earlier observations (Sugiura et al., 1999), 2-AG
also induced Ca2+ transients even in nanomolar concentration
(Figures 4F–J,N). Concentration-response curve of 1- and 2-AG
clearly demonstrates that potency of 2-AG (EC50 = 0.6 µM) is
threefold higher than that of 1-AG (EC50 = 1.9 µM), and 2-AG
was also found to be more efficacious. (Figure 4N; Table 2).
To demonstrate that 1- and 2-AG induce Ca2+ signals
through a CB1 receptor mediated pathway, we applied the
selective CB1 antagonist AM251. Effects of 1-AG were exclusively
mediated by CB1 receptors, since application of AM251
prevented the raise in intracellular Ca2+ in response to 10 µM
1-AG in 99.37± 0.51% of the cells (Figure 4K).
Application of AM251 completely abolished 2-AG evoked
Ca2+ transients also in the majority of the cells (Figure 4L),
however, 2.33 ± 0.89% of COS7 cells still showed responses to
1 µM 2-AG. Preincubation with AM251 caused a pronounced
decrease in, but could not fully prevent the 2-AG induced raise of,
intracellular Ca2+ concentration in these cells (data not shown).
Preincubation of the cells with AM251 at 5 µM caused an
apparent drop of the baseline in case of 6.16 ± 0.91 of the
cells (Figure 4M). This may most probably be the result of the
inhibition of a basal endocannabinoid tone by AM251, but, as an
inverse agonist, it may also decrease constitutive CB1 receptor
activity. Thus, it is very likely that the AM251-induced drop
of the baseline is CB1-dependent, but we cannot exclude other
mechanisms in the background of this phenomenon, such as the
inhibition of adenosine A1 receptors by AM251.
Accumulation of 1-AG Compensates the
Decreasing 2-AG Concentration and
Consequent Drop in Biological
Responses
Isomerization of 2-AG creates an interesting situation, since
both 1- and 2-isomers of arachidonoylglycerol target CB1 and
it is very likely that they will compete for the ligand binding
sites of CB1. However, depending on the relative concentration
of the two isomers with different potency and ligand binding
sites available in the biological environment, combined effects
of 1-AG and 2-AG may be either additive or antagonistic. We
hypothesized that, as isomerization proceeds after the moment
of 2-AG mobilization, the antagonistic effect of accumulating
1-AG becomes gradually more pronounced, resulting in the
attenuation of 2-AG evoked biological responses. To investigate
this possibility, we first calculated the change in ratio of the two
isomers over 10 min. Based on our measurements (Figure 1C),
the amounts of 2-AG and 1-AG change so that, 0.5, 2.6, 4.2,
and 9.8 min after dissolving 2-AG in HBSS, their ratio is
approximately 9:1, 8:2, 6:4, and 5:5, respectively. Thus, in this
experiment we treated transfected COS7 either with 2-AG alone
in a descending serial dilution (0.9, 0.8, 0.6, and 0.5 µM), or with
a mixture containing increasing quantities of 1-AG (0.1, 0.2, 0.4,
and 0.5 µM) complementing the decreasing concentration of 2-
AG to mimic the progress of isomerization. As expected, the drop
in effective 2-AG concentration was paralleled by a pronounced
diminution of evoked Ca2+ transients (Figure 5; Table 3).
Surprisingly, however, effects of 1-AG on 2-AG evoked Ca2+
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FIGURE 4 | Ca2+ transients induced by 1-AG and 2-AG. (A–E) Average Ca2+ transients induced by 10−8 (A), 10−7 (B), 10−6 (C), 10−5 (D), or 10−4 M (E)
1-AG (blue arrowhead). (F–J) Population average of Ca2+ transients in response to application of 2-AG in 10−8 (F), 10−7 (G), 10−6 (H), 10−5 (I), or 10−4 M (J)
(magenta arrowhead). (K–L) Application of AM251 in 5 µM (yellow arrowhead) prevents 10 µM 1-AG (K, blue arrowhead) and 1 µM 2-AG (L, magenta arrowhead)
from evoking Ca2+ transients. (M) AM251 in 5 µM (yellow arrowhead) induced a drop in the baseline in case of several cells. 2-AG in 1 µM (magenta arrowhead)
failed to evoke any biological response in these cells. (N) Standard concentration-response curves of 1-AG and 2-AG. Each data point represents an average of
AUC value of Ca2+ transients induced by various concentrations of 1-AG (as shown in A–E, blue) or 2-AG (based on F–J, magenta), expressed as percentage of
response to 180 µM ATP (black arrowheads).
transients were strongly dependent on the relative concentration
of the two isomers. Although we observed a weak antagonistic
effect of 0.1 µM 1-AG against 0.9 µM 2-AG, gradually increasing
concentration of 1-AG proved to be additive and increased Ca2+
signals evoked by declining quantities of 2-AG. The slope of
concentration-response curve of decreasing [2-AG] – increasing
[1-AG] pairs mimicked surprisingly well the time-dependent
minor and not significant changes of 2-AG induced Ca2+
responses (Figure 5; Table 3). Our measurements showed also
that the effect of 1-AG on 2-AG dependent cellular responses is
neutral at approximately at 0.8 µM 2-AG to 0.2 µM 1-AG ratio,
that is reached in 2.3 min from the moment when 2-AG meets
the aqueous medium (Figure 5).
DISCUSSION
Endogenous cannabinoids are ubiquitous intercellular
messengers playing essential role in a variety of physiological
and pathological processes. Although the endocannabinoid
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TABLE 2 | Area under the curve values of Ca2+ transients (expressed as
percentage of response to 180 µM ATP) in response to various
concentration of 1-AG and 2-AG.
Concentration 2-AG 1-AG
AUC (% of
ATP
response)
n AUC (% of
ATP
response)
n
10 nM 18.81 ± 4.99 133 6.45 ± 3.12 129
100 nM 35.24 ± 6.45 137 13.98 ± 5.99 130
1 µM 64.84 ± 5.11 145 32.26 ± 4.24 134
10 µM 83.67 ± 5.12 160 50.91 ± 6.11 137
100 µM 85.19 ± 4.23 159 61.99 ± 5.01 144
FIGURE 5 | CB1 receptor mediated intracellular Ca2+ increase in
response to application of 2-AG alone and in combination with 1-AG.
Each data point represents an AUC value of Ca2+ transients expressed as
percentage of response to 180 µM ATP. Decreasing concentrations of 2-AG
induce diminished Ca2+ transients (magenta). This effect is compensated by
increasing amounts of 1-AG, i.e., 1-AG at low concentration acts as
competitive antagonist, but its effect turns to additive as its concentration
increases (blue). The values on the top abscissa were calculated from the ratio
of the artificial mixtures of the two isomers with the aid of Figure 1E.
∗∗p < 0.01; ∗∗∗p < 0.005.
system has been extensively investigated in practically every
type of mammalian tissue (Kano et al., 2009; Maccarrone et al.,
2015), several questions and controversies remain to be solved
(Piomelli, 2014). One of these issues involve the mechanisms
that decreases the concentration and terminates the effects
of the endocannabinoid 2-AG, since besides the enzymatic
degradative pathways, 2-AG, as member of 2-monoglycerol
family, is chemically unstable and prone to acyl migration which
results in the formation of 1-AG (Martin, 1953). This molecular
rearrangement generates difficulties when quantifying amounts
of 2-AG from biological samples (Vogeser and Schelling, 2007;
Astarita and Piomelli, 2009; Pastor et al., 2014) and interpreting
the effects of 2-AG at cannabinoid and TRP receptors (Zygmunt
et al., 2013). Here we investigated the kinetics of 2-AG
isomerization into 1-AG and found that acyl migration is a rapid
molecular rearrangement with a half-time of 16.16 min in HBSS
TABLE 3 | Area under the curve values of Ca2+ transients in response to
2-AG alone (magenta rows) and in combination with 1-AG (blue rows)
(expressed as percentage of response to 180 µM ATP).
Concentration of AUC (% of ATP response) n
2-AG (µM) 1-AG (µM)
0.9 0 62.05 ± 3.85 152
0.1 56.13 ± 2.44 142
0.8 0 55.85 ± 4.02 150
0.2 54.83 ± 1.56 144
0.5 0 46.41 ± 2.28 147
0.5 53.57 ± 2.9 145
0.1 0 35.07 ± 3.12 145
0.9 51.89 ± 2.12 148
and 8.8 min in HBSS containing 10% serum at 37◦C. Although
our measurements were carried out in cell-free physiological
solutions, these results may indicate the biological relevance of
2-AG isomerization in certain cellular environments, since 2-AG
degrading hydrolases decrease the amounts of 2-AG with a half-
life of 19–28 min depending on the cell density (Di Marzo et al.,
1999). In that case, acyl migration and 1-AG formation seems to
be approximately two times faster than enzymatic inactivation of
2-AG. Importantly, isomerization does not have an impact on
the findings of the cited paper, since 1- and 2-monoacyglycerols
are equally accepted by the investigated hydrolases, and their
catabolism results in the formation of the same end-products
(Tornqvist and Belfrage, 1976; Di Marzo et al., 1999). In many
other physiological conditions, however, where the half-life
of 2-AG signaling is shorter than the rate of isomerization,
formation of 1-AG is unlikely to play physiologically relevant
role. This may be the case in 2-AG mediated retrograde synaptic
transmission, where the half-lives of depolarization induced
suppression of excitation of inhibition has been shown to fall in
the 15–40 s range (Kano et al., 2009).
Earlier studies demonstrated, that isomerization of 2-AG
depends primarily on the pH and partly on the ionic strength
of the milieu, and found faster acyl migration with a half-life of
10 min in serum-free and 2.3 min in serum-supplemented RPMI
medium at 37◦C (Rouzer et al., 2002). Although we cannot fully
explain this difference, we assume that the faster isomerization
may be the result of the richer and well supplemented RPMI
medium used in the cited study. The somewhat slower chemical
transformation which we found still indicates that, regardless of
the presence of monoacylglycerol degrading enzymes, release of
2-AG into aqueous extracellular space leads to the formation
and possibly to the temporary accumulation of 1-AG, which
gives special importance to bioactivity or inactivity of 1-AG at
cannabinoid receptors.
Therefore, we next investigated if 1-AG has any CB1 mediated
biological activity, and found that 1-AG transiently increases
intracellular Ca2+ concentration in a dose dependent manner.
This finding, in good agreement with earlier and frequently
overlooked studies (Sugiura et al., 1999), demonstrates that 1-
AG is indeed a bioactive molecule that activates CB1. The
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FIGURE 6 | Effects of 1-AG on 2-AG mediated CB1 receptor activation and consequent Ca2+ signaling. At the beginning of isomerization (left), 1-AG is
present in low concentration and exerts a weak antagonistic effect against 2-AG at CB1. As isomerization continues (right), 2-AG is gradually replaced by 1-AG,
and the activation of CB1 by the increasing concentration of 1-AG becomes more pronounced. Thus, 1-AG can now compensate the decrease in the concentration
of 2-AG and the consequent diminution of Ca2+ signals by maintaining CB1 activation.
EC50 of 1-AG was found to be one order of magnitude
higher than that of 2-AG, and 2-AG was more efficacious
in producing biological responses in CB1 transfected COS7
cells. However, 1-AG can also be considered as a high efficacy
agonist at CB1 receptor, and isomerization of 2-AG, therefore,
does not represent a non-enzymatic inactivation mechanism,
but yields another bioactive molecule activating the same
receptors as its precursor. We have to add, however, that during
physiological conditions, a cellular environment may never
reach such a high concentration of 1-AG that evokes maximal
response. Thus, 1-AG is likely to incompletely activate CB1
receptors.
Acyl migration following 2-AG release creates a rather unique
situation, when the monoacylglycerol concentration is relatively
constant, but the ratio of the two isomers changes rapidly as 2-
AG is gradually replaced by 1-AG, and the two isomers may
compete for ligand binding sites of CB1. Therefore, we next
studied the biological consequences of this process by preparing
mixtures of the two isomers in a ratio that simulates the time-
dependent change in their relative quantities. The moderate and
not significant diminution of effects of 2-AG on Ca2+ signaling
over time was surprisingly similar to that of the appropriate
artificial mixtures of the two isomers representing given time
point of isomerization. Importantly, results of both experiments
were significantly different from the more pronounced decline
evoked by decreasing quantities of 2-AG alone indicating, that
accumulating 1-AG stabilizes the cannabinoid signal and masks
the biological consequences of isomerization-related drop in 2-
AG concentration. This may explain why chemical instability
of 2-AG did not have any obvious impact on experimental
settings with 5–10 min or even longer time frames (Szabo et al.,
2006; De Luca et al., 2014; Stanley and O’Sullivan, 2014; Griebel
et al., 2015), and it is also very likely that such measurements
result in data mirroring at least partly or mostly effects of 1-AG
(Figure 6).
Bioactivity of 1-AG at CB1 and its ability to effectively
compensate the rapid elimination of 2-AG (Figure 6) may
represent an essential mechanism in maintaining long-lasting
effects of 2-AG and also basal endocannabinoid tone. However,
our results and interpretation have certain limitations. We
carried out experiments on transfected cell cultures, which
may be different from most in vivo conditions in terms
of cell physiology and metabolism, intercellular connections
and extracellular environment. For instance, various enzymes
degrading monoacylglycerols may effectively modify the ratio of
the two isomers. MGL equally accepts both 1-AG and 2-AG,
whereas ABHD6 and ABHD12 show preference to 1-AG over
the 2-isomer (Navia-Paldanius et al., 2012). Thus, differential
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expression of these hydrolases in various types of cells and tissues
may result in highly different 1-AG/2-AG ratios. Moreover,
2-AG release into aqueous extracellular space is frequently
mentioned as an important step of cannabinoid signaling, but
its proper mechanism is poorly understood (Bisogno et al.,
1997; Sugiura and Waku, 2000; Di Marzo et al., 2005), and is
further complicated by lateral diffusion, i.e., 2-AG is dissolved in,
and travels along cell membranes, which may delay or prohibit
acyl migration (Makriyannis et al., 2005; Hurst et al., 2010).
Thus, biological processes associated with 2-AG release may
represent composite effects of various mixtures of the 1- and 2-
isomers. Fast endocannabinoid signaling, such as homosynaptic
retrograde neurotransmission is most likely dominated by 2-
AG, whereas in case of prolonged effects of cannabinoids,
like tonic cannabinoid receptor activation (Sagar et al., 2010),
participation of 1-AG in stabilizing the net cannabinoid signal
and maintaining CB1 activation may be more prominent. This
latter possibility opens the question if prolonged incubation
with the two isomers induce differential degrees of CB1
desensitization which may further diversify the outcome of
isomerization.
Importantly, commercially available 2-AG preparations
already contain approximately 10% 1-AG, therefore the
isomerization process starts at 9:1 ratio. Although 1-AG masks
the isomerization-associated drop in 2-AG concentration, the
strength of the evoked biological responses will necessarily reflect
the effects of various mixtures of the two isomers in only several
minutes. Investigators should be aware of acyl migration in
experiments employing 2-AG, and choose carefully a time frame
short enough to prevent formation of 1-AG so that the results
can reliably be associated with 2-AG.
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